LaBarre Michael J.'s Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Jul 24, 2024
- Accession no.
- 0001415889-24-020055
- Filed
- Jul 24, 2024
- Trade date
- Jul 23-24, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.10M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaBarre Michael J.CIK 0001507174 | Officer (SVP, CHIEF TECHNICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $8.11 | +$81,100 | 178,176 | Direct | |
| Jul 23, 2024 | Common Stock | SSaleDisposed | −4,709 | $54.46 | −$256,452.14 | 173,467 | Direct | |
| Jul 23, 2024 | Common Stock | SSaleDisposed | −5,291 | $55.27 | −$292,433.57 | 168,176 | Direct | |
| Jul 24, 2024 | Common Stock | MOption exerciseAcquired | +1,715 | $8.11 | +$13,908.65 | 169,891 | Direct | |
| Jul 24, 2024 | Common Stock | MOption exerciseAcquired | +8,285 | $16.65 | +$137,945.25 | 178,176 | Direct | |
| Jul 24, 2024 | Common Stock | SSaleDisposed | −10,000 | $55.12 | −$551,200 | 168,176 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 1,715 | Direct | |
| Jul 24, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Jul 24, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 51,861 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.